COM:AKEBIA
Akebia Therapeutics, Inc.
- Stock
Last Close
1.82
22/11 21:00
Market Cap
226.36M
Beta: -
Volume Today
1.99M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -13.17M - | -37.03M 181.26% | -60.72M 63.95% | -135.75M 123.58% | -76.91M 43.34% | -143.59M 86.69% | -279.66M 94.76% | -383.46M 37.12% | -282.84M 26.24% | -92.56M 67.27% | -51.92M 43.90% | |
depreciation and amortization | 1.28K - | 49K 3,722.15% | 96K 95.92% | 296K 208.33% | 617K 108.45% | 2.42M 292.38% | 38.65M 1,496.28% | 33.59M 13.08% | 37.97M 13.04% | 37.70M 0.72% | 41.85M 11.01% | |
deferred income tax | -2.42M - | -28.34M - | -6.63M 76.60% | 204.08M 3,177.64% | 36.58M 82.08% | 6.79M - | ||||||
stock based compensation | 1.56M - | 6.01M 284.33% | 4.71M 21.56% | 5.83M 23.57% | 8.87M 52.22% | 19.04M 114.73% | 11.93M 37.37% | 24.46M 105.12% | 22.73M 7.05% | 17.85M 21.49% | 9.32M 47.80% | |
change in working capital | 1.93M - | 3.22M 67.06% | 2.94M 8.78% | 186.73M 6,249.27% | 7.25M 96.12% | 36.02M 396.94% | -99.07M 375.05% | -13.67M 86.20% | -108.42M 693.11% | -1.44M 98.68% | -20.73M 1,344.39% | |
accounts receivables | -49.71K - | 87K 275.03% | -393K - | 33.38M 8,594.66% | -22.20M 166.49% | 12.01M 154.11% | -24.02M 300% | 11.70M 148.68% | 994K 91.50% | |||
inventory | -773K - | 16.79M - | 26K 99.85% | -29.14M 112,184.62% | 6.16M 121.15% | -25.85M 519.39% | 19.79M 176.58% | -2.54M 112.84% | ||||
accounts payables | 4.06M - | 231K 94.31% | -274K 218.61% | 4.96M 1,909.85% | 13.72M 176.61% | 1.37M 90.00% | 3.68M 168.08% | -11.73M 419.06% | 1.50M 112.79% | -5.24M 449.37% | ||
other working capital | 1.98M - | -151K 107.63% | 2.71M 1,894.70% | 187.01M 6,800.59% | -14.11M 107.54% | -11.11M 21.26% | -49.10M 341.99% | -35.52M 27.66% | -46.81M 31.79% | -34.42M 26.47% | -13.94M 59.52% | |
other non cash items | 760.42K - | 268K 64.76% | 558K 108.21% | 800K 43.37% | 4.02M 402.87% | 16.95M 321.40% | 77.35M 356.24% | 24.61M 68.18% | 41.01M 66.63% | -34.70M 184.62% | -8.69M 74.97% | |
net cash provided by operating activities | -11.33M - | -27.48M 142.53% | -52.41M 90.69% | 57.91M 210.49% | -56.16M 196.98% | -97.49M 73.60% | -257.44M 164.06% | -110.39M 57.12% | -252.97M 129.16% | -73.15M 71.08% | -23.38M 68.03% | |
investments in property plant and equipment | -19.73K - | -229K 1,060.55% | -414K 80.79% | -2.66M 543.00% | -1.62M 39.07% | -1.61M 0.99% | -6.66M 314.38% | -317K 95.24% | -59K 81.39% | -114K 93.22% | ||
acquisitions net | 229K - | 414K 80.79% | 2.66M 543.00% | 1.62M 39.07% | 6.15M 278.98% | 39.69M - | ||||||
purchases of investments | -13.39M - | -77.71M 480.13% | -77.17M 0.69% | -147.01M 90.49% | -330.64M 124.91% | -224.22M 32.19% | -99.93M - | |||||
sales maturities of investments | 1.99M - | 12.59M 532.41% | 63.90M 407.76% | 162.38M 154.11% | 155.00M 4.54% | 256.27M 65.34% | 217.83M 15.00% | 60.24M 72.34% | 40M 33.60% | |||
other investing activites | -229K - | -414K 80.79% | -2.66M 543.00% | -1.62M 39.07% | -39.69M - | |||||||
net cash used for investing activites | -11.42M - | -65.35M 472.02% | -13.69M 79.05% | 12.71M 192.82% | -177.26M 1,495.20% | 36.59M 120.64% | 211.18M 477.08% | -40.00M 118.94% | 39.94M 199.84% | -114K 100.29% | ||
debt repayment | -3K - | -7K 133.33% | -20K 185.71% | -5K 75% | -19K 280% | -15M 78,847.37% | -19.98M 33.17% | -44.78M 124.20% | -33M 26.31% | -32M 3.03% | ||
common stock issued | 5.34K - | 104.33M 1,955,072.41% | 82.75M 20.68% | 66.74M 19.35% | 114.58M 71.69% | 95.45M 16.69% | 25.79M 72.99% | 209.42M 712.17% | 88.20M 57.88% | 7.12M 91.93% | 6.79M 4.59% | |
common stock repurchased | -162K - | -426K - | ||||||||||
dividends paid | ||||||||||||
other financing activites | 42.33M - | 237K 99.44% | 350K 47.68% | 230K 34.29% | 1.67M 623.91% | 1.13M 32.19% | 78.61M 6,862.89% | 42.28M 46.22% | 90.31M 113.62% | 40.48M 55.18% | ||
net cash used provided by financing activities | 42.33M - | 104.40M 146.63% | 83.09M 20.41% | 66.95M 19.43% | 116.24M 73.63% | 96.56M 16.93% | 88.97M 7.86% | 231.72M 160.45% | 133.73M 42.29% | 14.60M 89.08% | -25.21M 272.67% | |
effect of forex changes on cash | ||||||||||||
net change in cash | 19.57M - | 11.56M 40.92% | 17.00M 46.98% | 137.56M 709.25% | -117.18M 185.19% | 35.66M 130.43% | 42.70M 19.75% | 81.33M 90.44% | -79.29M 197.50% | -58.67M 26.01% | -47.54M 18.97% | |
cash at beginning of period | 1.64M - | 21.21M 1,192.78% | 32.78M 54.51% | 49.78M 51.85% | 187.34M 276.34% | 71.44M 61.87% | 107.10M 49.92% | 149.80M 39.87% | 231.13M 54.29% | 151.84M 34.31% | 90.47M 40.42% | |
cash at end of period | 21.22M - | 32.78M 54.51% | 49.78M 51.85% | 187.34M 276.34% | 70.16M 62.55% | 107.10M 52.66% | 149.80M 39.87% | 231.13M 54.29% | 151.84M 34.31% | 93.17M 38.64% | 42.92M 53.93% | |
operating cash flow | -11.33M - | -27.48M 142.53% | -52.41M 90.69% | 57.91M 210.49% | -56.16M 196.98% | -97.49M 73.60% | -257.44M 164.06% | -110.39M 57.12% | -252.97M 129.16% | -73.15M 71.08% | -23.38M 68.03% | |
capital expenditure | -19.73K - | -229K 1,060.55% | -414K 80.79% | -2.66M 543.00% | -1.62M 39.07% | -1.61M 0.99% | -6.66M 314.38% | -317K 95.24% | -59K 81.39% | -114K 93.22% | ||
free cash flow | -11.35M - | -27.71M 144.13% | -52.82M 90.61% | 55.24M 204.59% | -57.78M 204.59% | -99.10M 71.51% | -264.10M 166.49% | -110.70M 58.08% | -253.02M 128.56% | -73.27M 71.04% | -23.38M 68.08% |
All numbers in USD (except ratios and percentages)